These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 18085063)

  • 1. The pathology of dengue hemorrhagic fever.
    Leong AS; Wong KT; Leong TY; Tan PH; Wannakrairot P
    Semin Diagn Pathol; 2007 Nov; 24(4):227-36. PubMed ID: 18085063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
    Pang T; Cardosa MJ; Guzman MG
    Immunol Cell Biol; 2007 Jan; 85(1):43-5. PubMed ID: 17130899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelium: the battlefield of dengue viruses.
    Basu A; Chaturvedi UC
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):287-99. PubMed ID: 18522648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards understanding the pathogenesis of dengue hemorrhagic fever.
    Pang X; Zhang R; Cheng G
    Virol Sin; 2017 Feb; 32(1):16-22. PubMed ID: 27853992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells.
    Cabello-Gutiérrez C; Manjarrez-Zavala ME; Huerta-Zepeda A; Cime-Castillo J; Monroy-Martínez V; Correa BB; Ruiz-Ordaz BH
    Thromb Haemost; 2009 May; 101(5):916-28. PubMed ID: 19404546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Autoimmune Mechanism in Dengue Hemorrhagic Fever.
    Lardo S; Soesatyo MH; Juffrie J; Umniyati SR
    Acta Med Indones; 2018 Jan; 50(1):70-79. PubMed ID: 29686179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathogenesis of dengue virus infection.
    Lei HY; Yeh TM; Liu HS; Lin YS; Chen SH; Liu CC
    J Biomed Sci; 2001 Sep; 8(5):377-88. PubMed ID: 11549879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DENGUE VIRUS VIRULENCE AND DISEASES SEVERITY.
    Prommalikit O; Thisyakorn U
    Southeast Asian J Trop Med Public Health; 2015; 46 Suppl 1():35-42. PubMed ID: 26506730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control.
    Wang WH; Urbina AN; Chang MR; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    J Microbiol Immunol Infect; 2020 Dec; 53(6):963-978. PubMed ID: 32265181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
    Her Z; Kam YW; Gan VC; Lee B; Thein TL; Tan JJ; ; Lee LK; Fink K; Lye DC; Rénia L; Leo YS; Ng LF
    J Infect Dis; 2017 Jan; 215(1):42-51. PubMed ID: 28077582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of interacting immunological components in dengue pathogenesis.
    Nielsen DG
    Virol J; 2009 Nov; 6():211. PubMed ID: 19941667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dendritic cells as targets of dengue virus infection.
    Marovich M; Grouard-Vogel G; Louder M; Eller M; Sun W; Wu SJ; Putvatana R; Murphy G; Tassaneetrithep B; Burgess T; Birx D; Hayes C; Schlesinger-Frankel S; Mascola J
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):219-24. PubMed ID: 11924831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cells in dengue hemorrhagic fever.
    Srikiatkhachorn A; Kelley JF
    Antiviral Res; 2014 Sep; 109():160-70. PubMed ID: 25025934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction.
    Luplertlop N; Missé D; Bray D; Deleuze V; Gonzalez JP; Leardkamolkarn V; Yssel H; Veas F
    EMBO Rep; 2006 Nov; 7(11):1176-81. PubMed ID: 17028575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease.
    Tian Y; Seumois G; De-Oliveira-Pinto LM; Mateus J; Herrera-de la Mata S; Kim C; Hinz D; Goonawardhana NDS; de Silva AD; Premawansa S; Premawansa G; Wijewickrama A; Balmaseda A; Grifoni A; Vijayanand P; Harris E; Peters B; Sette A; Weiskopf D
    Cell Rep; 2019 Dec; 29(13):4482-4495.e4. PubMed ID: 31875555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation.
    Wang L; Chen RF; Liu JW; Lee IK; Lee CP; Kuo HC; Huang SK; Yang KD
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e934. PubMed ID: 21245921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
    Chuang YC; Chen HR; Yeh TM
    Mediators Inflamm; 2015; 2015():547094. PubMed ID: 25821355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis.
    Chaturvedi UC; Agarwal R; Elbishbishi EA; Mustafa AS
    FEMS Immunol Med Microbiol; 2000 Jul; 28(3):183-8. PubMed ID: 10865168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.
    Chen HR; Lai YC; Yeh TM
    J Biomed Sci; 2018 Jul; 25(1):58. PubMed ID: 30037331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.